Senores Pharmaceuticals Ltd (SENORES) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 10039497,
    "name": "Senores Pharma.",
    "stock_name": "Senores Pharma.",
    "full_name": "Senores Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/senores-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "806.65",
    "chg": 6.95,
    "chgp": "0.87%",
    "dir": 1,
    "prev_price": "799.70",
    "mcapval": "3,787.00 Cr",
    "mcap": "Small Cap",
    "scripcode": "544319",
    "symbol": "SENORES",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0RB801010",
    "curr_date": "Dec 19",
    "curr_time": "",
    "bse_nse_vol": "5.11 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 19, 2025",
    "traded_date_str": "2025 12 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/senores-pharma-10039497-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Senores Pharma. Sees Revised Market Evaluation Amidst Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharma-upgraded-from-sell-to-hold-by-marketsmojo-on-16-may-2025-3763707",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SenoresPharma_mojoScore_3763707.png",
        "date": "2025-12-19 10:10:34",
        "description": "Senores Pharma., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment comes amid notable quarterly results and evolving market dynamics, signalling a nuanced change in investor perception."
      },
      {
        "title": "Senores Pharmaceuticals Hits New 52-Week High at Rs.847.9",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-hits-new-52-week-high-at-rs8479-3758651",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SenoresPharmace_priceRelatedfactors_3758651.png",
        "date": "2025-12-15 10:23:16",
        "description": "Senores Pharmaceuticals has reached a significant milestone by touching a new 52-week high of Rs.847.9, marking a notable moment in the stock's recent performance within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Senores Pharmaceuticals Stock Hits All-Time High at Rs.835.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-stock-hits-all-time-high-at-rs83565-3758476",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SenoresPharmace_priceRelatedfactors_3758476.png",
        "date": "2025-12-15 09:43:42",
        "description": "Senores Pharmaceuticals has reached a significant milestone by touching an all-time high of Rs.835.65, marking a notable event in the Pharmaceuticals & Biotechnology sector. This achievement reflects the company’s recent performance trends and market dynamics."
      },
      {
        "title": "Senores Pharma. Sees Revised Market Assessment Amidst Strong Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/senores-pharma-upgraded-to-hold-by-marketsmojo-on-improving-fundamentals-3735181",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharma_mojoScore_3735181.png",
        "date": "2025-11-28 10:05:28",
        "description": "Senores Pharma., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical parameters. This adjustment follows a period marked by notable growth in sales and profits, alongside a valuation that remains on the higher side relative to its peers."
      },
      {
        "title": "Senores Pharmaceuticals Hits New 52-Week High of Rs.832 Marking Significant Milestone",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-hits-new-52-week-high-at-rs832-3718318",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharmace_priceRelatedfactors_3718318.png",
        "date": "2025-11-20 14:48:07",
        "description": "Senores Pharmaceuticals has reached a new 52-week high of Rs.832, marking a notable milestone in its stock performance amid a broadly positive market environment."
      },
      {
        "title": "Senores Pharmaceuticals Hits All-Time High Amid Strong Market Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-stock-hits-all-time-high-on-20-nov-2025-3718277",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharmace_priceRelatedfactors_3718277.png",
        "date": "2025-11-20 14:14:58",
        "description": "Senores Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, has reached an all-time high, marking a significant milestone in its market journey. The stock's recent performance reflects robust momentum, supported by consistent price strength and favourable trading patterns."
      },
      {
        "title": "Why is Senores Pharma. falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-senores-pharma-fallingrising-3681692",
        "imagepath": "",
        "date": "2025-11-08 00:46:35",
        "description": "As of 07-Nov, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 822.30, reflecting a rise of 16.5 or 2.05%. The stock has recently hit a new 52-week and all-time high of Rs. 831.65 today, demonstrating strong performance with a 7.24% gain over the last two days. Additionally, it has outperformed its sector by 2.39%. The stock's performance over the past week shows a return of +6.82%, while it has achieved a remarkable +16.09% over the past month. The company has shown impressive financial health, with net sales growing at an annual rate of 85.60% and a net profit increase of 138.15%, contributing to positive investor sentiment and driving the stock's upward movement.\n\nIn the broader market context, while the Sensex has declined by 0.86% over the past week, Senores Pharmaceuticals has significantly outperformed this benchmark, indicating strong investor confidence in the company rela..."
      },
      {
        "title": "Are Senores Pharma. latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-senores-pharma-latest-results-good-or-bad-3680589",
        "imagepath": "",
        "date": "2025-11-07 19:27:43",
        "description": "Senores Pharmaceuticals has reported notable financial results for the quarter ended September 2025, highlighting a significant operational performance. The company achieved net sales of ₹161.76 crores, reflecting a year-on-year growth of 60.75% and a sequential increase of 17.23%. This marks an all-time high for the company, indicating strong demand across its product portfolio. \n\nThe operating margin for the quarter expanded to 32.28%, up from 23.68% in the same quarter last year, showcasing improved operational efficiency and economies of scale as the company continues to grow. The profit after tax (PAT) also saw substantial growth, reaching ₹32.38 crores, which is a 152.18% increase year-on-year and a 64.12% rise sequentially. The PAT margin improved to 19.64%, further demonstrating the company's ability to convert revenue growth into profitability.\n\nIn terms of operational dynamics, the company has sho..."
      },
      {
        "title": "Senores Pharmaceuticals Hits New 52-Week High of Rs. 831.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/senores-pharmaceuticals-hits-new-52-week-high-of-rs-83165-3680045",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SenoresPharmace_priceRelatedfactors_3680045.png",
        "date": "2025-11-07 15:44:41",
        "description": "Senores Pharmaceuticals achieved a new 52-week high of Rs. 831.65 on November 7, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The stock has outperformed its sector and demonstrated resilience with consecutive gains, trading above key moving averages and showing significant recovery from its previous low."
      }
    ],
    "total": 154,
    "sid": "10039497",
    "stock_news_url": "https://www.marketsmojo.com/news/senores-pharmaceuticals-10039497"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Senores Pharma. Sees Revised Market Evaluation Amidst Strong Financial Trends

2025-12-19 10:10:34

Senores Pharma., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical outlook. This adjustment comes amid notable quarterly results and evolving market dynamics, signalling a nuanced change in investor perception.

Senores Pharmaceuticals Hits New 52-Week High at Rs.847.9

2025-12-15 10:23:16

Senores Pharmaceuticals has reached a significant milestone by touching a new 52-week high of Rs.847.9, marking a notable moment in the stock's recent performance within the Pharmaceuticals & Biotechnology sector.

Senores Pharmaceuticals Stock Hits All-Time High at Rs.835.65

2025-12-15 09:43:42

Senores Pharmaceuticals has reached a significant milestone by touching an all-time high of Rs.835.65, marking a notable event in the Pharmaceuticals & Biotechnology sector. This achievement reflects the company’s recent performance trends and market dynamics.

Senores Pharma. Sees Revised Market Assessment Amidst Strong Financial Trends

2025-11-28 10:05:28

Senores Pharma., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting recent shifts in its financial and technical parameters. This adjustment follows a period marked by notable growth in sales and profits, alongside a valuation that remains on the higher side relative to its peers.

Senores Pharmaceuticals Hits New 52-Week High of Rs.832 Marking Significant Milestone

2025-11-20 14:48:07

Senores Pharmaceuticals has reached a new 52-week high of Rs.832, marking a notable milestone in its stock performance amid a broadly positive market environment.

Senores Pharmaceuticals Hits All-Time High Amid Strong Market Momentum

2025-11-20 14:14:58

Senores Pharmaceuticals, a key player in the Pharmaceuticals & Biotechnology sector, has reached an all-time high, marking a significant milestone in its market journey. The stock's recent performance reflects robust momentum, supported by consistent price strength and favourable trading patterns.

Why is Senores Pharma. falling/rising?

2025-11-08 00:46:35

As of 07-Nov, Senores Pharmaceuticals Ltd is experiencing a price increase, currently at 822.30, reflecting a rise of 16.5 or 2.05%. The stock has recently hit a new 52-week and all-time high of Rs. 831.65 today, demonstrating strong performance with a 7.24% gain over the last two days. Additionally, it has outperformed its sector by 2.39%. The stock's performance over the past week shows a return of +6.82%, while it has achieved a remarkable +16.09% over the past month. The company has shown impressive financial health, with net sales growing at an annual rate of 85.60% and a net profit increase of 138.15%, contributing to positive investor sentiment and driving the stock's upward movement. In the broader market context, while the Sensex has declined by 0.86% over the past week, Senores Pharmaceuticals has significantly outperformed this benchmark, indicating strong investor confidence in the company rela...

Are Senores Pharma. latest results good or bad?

2025-11-07 19:27:43

Senores Pharmaceuticals has reported notable financial results for the quarter ended September 2025, highlighting a significant operational performance. The company achieved net sales of ₹161.76 crores, reflecting a year-on-year growth of 60.75% and a sequential increase of 17.23%. This marks an all-time high for the company, indicating strong demand across its product portfolio. The operating margin for the quarter expanded to 32.28%, up from 23.68% in the same quarter last year, showcasing improved operational efficiency and economies of scale as the company continues to grow. The profit after tax (PAT) also saw substantial growth, reaching ₹32.38 crores, which is a 152.18% increase year-on-year and a 64.12% rise sequentially. The PAT margin improved to 19.64%, further demonstrating the company's ability to convert revenue growth into profitability. In terms of operational dynamics, the company has sho...

Senores Pharmaceuticals Hits New 52-Week High of Rs. 831.65

2025-11-07 15:44:41

Senores Pharmaceuticals achieved a new 52-week high of Rs. 831.65 on November 7, 2025, reflecting strong performance in the Pharmaceuticals & Biotechnology sector. The stock has outperformed its sector and demonstrated resilience with consecutive gains, trading above key moving averages and showing significant recovery from its previous low.

View All News